Advancements in respiratory and nutrition management have significantly improved the
survival of patients with cystic fibrosis (CF). With the availability of several nutrition …

Fibroblast growth factor 23 (FGF23) was identified at the turn of the century as the long-
sought circulating phosphatonin in human pathology. Since then, several clinical and …

Introduction: In recent years, guidelines for vitamin D supplementation have been updated
and prophylactic recommended doses have been increased in patients with cystic fibrosis …

This review article aims to summarize the literature findings regarding the role of
micronutrients in children with lung disease. The nutritional and respiratory statuses of …

The maximum rate of bone mass accumulation is during early adolescence. As such, a focus
on optimizing mineral nutrition in school age children, defined here as approximately 5 to 15 …

Cystic fibrosis is a monogenic disease with a multisystemic phenotype, ranging from
predisposition to chronic lung infection and inflammation to reduced bone mass. The exact …

Aim Vitamin D is a prominent modulator of immunity and respiratory function. It plays a vital
role in respiratory diseases such as cystic fibrosis (CF). S. However, there is a dearth of …

Purpose To conduct a solid evidence by synthesizing meta-analyses and updated RCTs
about the effects of vitamin D on all-cause mortality in different health conditions. Methods …

Backgound Increasing evidence suggests that vitamin D is associated with pulmonary
health, which may benefit children and young people diagnosed with Cystic Fibrosis …

Background Highly-effective CFTR-modulator therapy with elexa-/teza-/ivacaftor (ETI) has
led to improvements in pulmonary outcomes, sweat chloride, body mass index (BMI) and …